Precigen, Inc. Capex/Depreciation

Capex/Depreciation of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending June 30, 2022 was -0.44 (a 1.68% increase compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -24.34%
  • Annual Capex/Depreciation for 2021 was -0.31 (a 417.98% increase from previous year)
  • Annual Capex/Depreciation for 2020 was -0.06 (a -96.02% decrease from previous year)
  • Annual Capex/Depreciation for 2019 was -1.49 (a 25.81% increase from previous year)
  • Twelve month Capex/Depreciation ending June 30, 2022 was -0.54 (a 10.7% increase compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -957.46% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-0.54 -0.49 -0.26 0.06
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of Precigen, Inc.

Most recent Capex/Depreciationof PGEN including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of Precigen, Inc.

Precigen, Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.44 -0.44
2021 -0.69 -0.58 -0.25 0.15 -0.31
2020 0.49 -0.11 -0.06 -0.34 -0.06
2019 -0.05 -0.66 -5.61 -1.37 -1.49
2018 -0.88 -0.42 -0.38 -1.11 -1.19
2017 -0.92 -2.39 10.28 -0.67 -1.45
2016 -0.55 -1.72 -0.19 -0.15 -0.37
2015 -0.79 -0.08 -0.16 0.02 0.25
2014 0.03 -0.04 -0.02 0.15 -0.28
2013 0.1 0.0 0.1 -0.01 0.42
2012 -0.02 -0.03 0.58 -0.52
2011 -1.84 -1.84

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology